Teladoc Health, Inc.

NYSE:TDOC

Medical - Healthcare Information Services

Healthcare
$8.06 +2.57%

+$0.20 today

Market cap
$1.47B
Beta
2.14
P/E (TTM)
-8.1
EPS (TTM)
-$0.96
52W Low $4.40High $9.77

Volume 3.96M

Average 4.68M

TDOC Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Teladoc Health, Inc.NYSE: TDOC

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses turns negative

Q1 FY2026 other income / expenses was -$12.11M, compared with $9.34M a year earlier. Trailing-twelve-month other income / expenses was $5.97M.

Context

  • Other income / expenses amounted to 1.1% of revenue in FY2025, unchanged from a year earlier.
  • Other income / expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly other income / expenses holds near -$12.11M or moves back toward the trailing-twelve-month quarterly average of $1.49M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$12.11M-609.2% QoQ
Last fiscal yearDec 2025
$27.43M+0.7% YoY
LTMMar 2026
$5.97M-79.2% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-229.6%——
1 year+0.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
27.43M USD
Year-over-year change
+0.7%

Other Income / Expenses vs competitors

How TDOC compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -79.2% is the 8th highest of 11, against a peer median of +9.5%.
  • Other income / expenses amounts to 0.2% of revenue for TDOC, versus a peer median of 1.1%.
TDOC Competitors
Other Income / Expenses for TDOC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SDGRSchrödinger, Inc.LTM Sep 2026$76.77M USD+1972.1%—28.5%
AZTAAzenta, Inc.LTM Sep 2026$21.34M USD+735.7%-22.9%3.4%
IMNMImmunome, Inc.LTM Sep 2026$18.04M USD+57.2%+600.5%—
PHVSPharvaris N.V.LTM Sep 2026€14.39M EUR+118.3%——
NVCRNovoCure LimitedLTM Mar 2026$8.14M USD-78.0%+31.7%1.2%
PGNYProgyny, Inc.LTM Jun 2026$7.71M USD-38.2%+109.8%0.6%
TDOCTeladoc Health, Inc.LTM Mar 2026$5.97M USD-79.2%—0.2%
OMCLOmnicell, Inc.LTM Mar 2026$3.13M USD-85.3%—0.3%
OMDAOmada HealthLTM Mar 2026$2.06M USD+157.8%—0.7%
PHRPhreesia, Inc.LTM Apr 2026-$4.68M USD-314.0%—0.9%
EVOEvotec SELTM Mar 2026-€76.81M EUR-128.1%—10.3%
Peer median (excluding TDOC) —+9.5%+70.8%1.1%

Competitors are the stored peer set for TDOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.03B2.41B2.6B2.57B2.53B
Cost of Revenue650.26M743.99M760.03M751.27M771.59M
Gross Profit1.38B1.66B1.84B1.82B1.76B
Gross Margin68.0%69.1%70.8%70.8%69.5%
Research & Development311.88M333.63M348.52M307.27M277.92M
Selling, General & Admin1.11B1.3B1.37B1.35B1.09B
Operating Expenses1.65B15.32B2.09B2.84B2.02B
Depreciation & Amortization207.57M209.93M254.11M240.51M363.12M
EBITDA(31.42M)(7.54M)43.61M31.72M147.3M
EBITDA Margin-1.5%-0.3%1.7%1.2%5.8%
Operating Income(265.63M)(13.65B)(248.55M)(1.02B)(262.96M)
Operating Margin-13.1%-567.3%-9.6%-39.7%-10.4%
Interest Income776K12.67M46.78M57.07M36.77M
Interest Expense81.14M21.94M22.28M23.8M19.71M
Other Income / Expenses(119.03M)(10.13M)28.95M27.23M27.43M
Income Before Tax(384.66M)(13.66B)(219.61M)(993.65M)(235.53M)
Pre-Tax Margin-18.9%-567.7%-8.4%-38.7%-9.3%
Income Tax Expense44.14M(3.81M)760K7.59M(35.21M)
Net Income(428.79M)(13.66B)(220.37M)(1B)(200.32M)
Net Margin-21.1%-567.5%-8.5%-39.0%-7.9%
EPS (Basic)(2.73)(84.60)(1.36)(5.87)(1.14)
EPS (Diluted)(2.73)(84.60)(1.34)(5.87)(1.14)
Weighted Avg Shares156.94M161.46M162.17M170.56M176.22M
Weighted Avg Shares (Diluted)156.94M161.46M164.58M170.56M176.22M

Teladoc Health, Inc.

NYSE:TDOC

Intrinsic Alpha fair value

Locked

Current Price

$8.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.